» Articles » PMID: 6377913

Control of Glomerular Filtration Rate: Role of Intrarenally Formed Angiotensin II

Overview
Journal Am J Physiol
Specialty Physiology
Date 1984 Jun 1
PMID 6377913
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

This study was designed to investigate the role of intrarenally formed angiotensin II (ANG II) in controlling glomerular filtration rate (GFR) during reduction of renal artery pressure (RAP). The experimental design prevented renin released by the kidney from entering the systemic circulation and therefore prevented changes in circulating ANG II from influencing GFR control. In dogs with only a functional intrarenal renin-angiotensin system (RAS), GFR and renal blood flow (RBF) were not significantly altered by RAP reduction to 70 mmHg. After blockade of intrarenal ANG II formation with SQ 14225, reduction of RAP to 70 mmHg decreased GFR and filtration fraction to 75.6 +/- 7.0 and 59.0 +/- 4.1% of control, respectively, while RBF remained at 129.3 +/- 8.8% of control. Calculated efferent arteriolar resistance decreased considerably more when RAP was reduced after SQ 14225, whereas preglomerular resistance decreased to about the same level as observed prior to SQ 14225 infusion. After return of endogenously produced ANG II by recirculation of the renal venous blood or after infusion of ANG II (following SQ 14225) at a rate that restored RBF to the control level (with RAP held at 70 mmHg in each case), GFR, filtration fraction, and calculated efferent resistance were restored to control levels, but preglomerular resistance did not change. These results suggest that intrarenal ANG II formation plays an important role in maintaining GFR during reductions in RAP by constricting efferent arterioles.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Circulating Dipeptidyl Peptidase 3 Modulates Systemic and Renal Hemodynamics Through Cleavage of Angiotensin Peptides.

Picod A, Placier S, Genest M, Callebert J, Julian N, Zalc M Hypertension. 2024; 81(4):927-935.

PMID: 38334001 PMC: 10956665. DOI: 10.1161/HYPERTENSIONAHA.123.21913.


Glomerular microcirculation: Implications for diabetes, preeclampsia, and kidney injury.

Goligorsky M Acta Physiol (Oxf). 2023; 239(3):e14048.

PMID: 37688412 PMC: 10615779. DOI: 10.1111/apha.14048.


Role of Impaired Nutrient and Oxygen Deprivation Signaling and Deficient Autophagic Flux in Diabetic CKD Development: Implications for Understanding the Effects of Sodium-Glucose Cotransporter 2-Inhibitors.

Packer M J Am Soc Nephrol. 2020; 31(5):907-919.

PMID: 32276962 PMC: 7217421. DOI: 10.1681/ASN.2020010010.


Antihypertensive agents: a long way to safe drug prescribing in children.

Siddiqi N, Shatat I Pediatr Nephrol. 2019; 35(11):2049-2065.

PMID: 31676933 PMC: 7515858. DOI: 10.1007/s00467-019-04314-7.


The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature.

Busse L, McCurdy M, Ali O, Hall A, Chen H, Ostermann M Crit Care. 2017; 21(1):324.

PMID: 29282149 PMC: 5745607. DOI: 10.1186/s13054-017-1896-6.